Erlotinib Accord (erlotinib)
Generic
- Region
- 🇪🇺 EU
- Active substance
- erlotinib
- Company
- Accord Healthcare S.L.U.
- Status
- Application withdrawn
- Therapeutic area
- Carcinoma, Non-Small-Cell Lung; Pancreatic Neoplasms
- Designations
- Generic
- Application
- EMEA/H/C/005071
- ATC
- L01XE03
- Official record
- www.ema.europa.eu
Indication
Treatment of lung and pancreatic cancers
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Tarceva Authorised · Cheplapharm Registration GmbH
Follow Erlotinib Accord
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.